Results 151 to 160 of about 8,198,133 (306)

Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation. [PDF]

J Transl Med
Gonzalez-Garcia P, Moares N, Serrano-García I, Fernandez-Cisnal R, Luna-Espejo R, Ocaña-Cuesta J, Yi-He W, Muñoz-Miranda JP, Gabucio A, Fernandez-Ponce CM, Garcia-Cozar F.   +10 more
europepmc   +1 more source

Participation of Cyclophosphamide-Sensitive T Cells in Graft-vs-Host Reactions [PDF]

, 1976
Anthony L. Schwartz, S. Orbach‐Arbouys, Richard K. Gershon   +2 more
openalex   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation. [PDF]

Front Immunol
Niu X, Zhang P, Liu Z, Tang Y, Xu S, Wan X, Xu Z, Zhang G.   +7 more
europepmc   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

T-cell differentiation stage block bias confers hypermethylation and mediastinal preference in T-cell lymphoblastic lymphoma. [PDF]

Clin Transl Med
Wang J, Qian B, Yu X, Zhang Y, Zhou C, Yang T, Xia L, Zhang G, Zhang YX, Wang Y, Fang Y.   +10 more
europepmc   +1 more source

Glucocorticoid-Induced Inhibition of T Cell Growth Factor Production [PDF]

, 1979
Steven Gillis, Gerald R. Crabtree, Kendall A. Smith   +2 more
openalex   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Radiotherapy for human T-cell leukemia virus type 1-associated adult T-cell leukemia/lymphoma. [PDF]

J Radiat Res
Tokuyama K, Itaya T, Hara A, Tanabe M, Takata S, Kiyota T, Yamate T, Hatano Y, Ogata M, Takano K, Asayama Y.   +10 more
europepmc   +1 more source

Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens. [PDF]

, 1975
Hans Binz, Hans Wigzell
openalex   +1 more source